Whitepaper: EU MDR and the Impact on Chemical Substances in Medical Products
Register now to download the information!
In April 2017, the European Union (EU) adopted the new Medical Device Regulation (MDR), (EU) 2017/745. Manufacturers should be aware that this new regulation is a prerequisite for accessing European markets and has significantly changed market access structures in the EU.
This whitepaper outlines the implications of the new MDR for chemical substances used in the manufacture of medical devices. It also outlines proposed solutions and long-term considerations for ensuring compliance in the future.
Don't miss out on this opportunity to unlock the full potential of your medical products. Download our whitepaper today and take the first step towards transforming your operations!
In return for the whitepaper, we kindly ask for your e-mail address and your consent that we may continue to send you regular information about TÜV Rheinland products and news by e-mail in the future. The fields marked with * are mandatory.
Back to top
